Appropriate anti-thrombotic medication to each patient needs, health disorders and their complications (art of drugs combination), appropriate evaluation of hemorrhage risk during surgery are few of the many reasons why accurate primary hemostasis evaluation is needed.
Current devices on the market lack accuracy and sensitivity and aren’t relevant according to clinicians.
BlooDe is a new more sensitive and precise system that, amongst other things, make possible the adaptation of protocols to specific patient's hemostasis situation.
-Functional prototype – TRL 6
-Clinical study based on whole blood of healthy donors and patient with severe von Willebrand Disease successfully completed
- On-going clinical study
- Successful and accurate detection of vWF deficiency and of antiplatelet drugs’effect.
- Pre-industrial prototype launching
MARKETS AND APPLICATIONS
Medical : Pre-operative assessment
Pharma : testing new drugs
Prototype undergoing validation in a representative environment(TRL 5-6)
Franche-Comté University - CNRS
Co-development to orient the technology according to the needs of manufacturers
Business Developpement Manager
+33 (0)6 26 61 89 06